glp-1 vs glp 3 weight loss vs. Bariatric Surgery: 1- Surgery: 25-30% + TBWL for 10+ years GLP-1: 15-21% in trials, less in real-world 2- Metabolic Benefits: Surgery > GLP-1 3- Comorbidities: Greater resolution with Association between plausible genetic factors

This fact is causing some excitement in the hope that GSH may have a role in management and cessation of neurodegenerative processes involved in these conditions

Many stimulant-type weight loss medications like phentermine or diethylpropion are only recommended for short-term use (up to 12 weeks) due to risk of dependence and other side effects

With obesity linked to hypertension, dyslipidemia, sleep apnea, cardiovascular disease, fatty liver disease, and kidney complications, GLP-1 drugs have become platform therapies rather than single-indication products

Why Nature Chose Selenium

All our raw materials go through stringent testing to meet our high-quality standards

Tuchsen F, Jensen AA